A Trial of Post-Discharge Transitional Care for Patients With Chronic Liver Disease
ConditionLiver Diseases
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorIndiana University
About this trial
Patients with complications of advanced liver disease often have difficulties after hospital discharge that result in early hospital readmission. Poor outcomes for these patients during this transitional time could be improved through the use of innovative transitional care models. This proposal aims to examine the effect of a transitional care model, The Transitional Liver Clinic (TLC), in reducing hospital re-admissions, improving quality of life, and improving patient experience.
Eligibility criteria
Qualifiers
Male or female age ≥18
Diagnosis of advanced liver disease, defined as either (must meet either a or b)
biopsy
characteristic clinical, laboratory, and imaging findings
Disqualifiers
discharge under hospice
listed for liver transplant with MELD-Na ≥ 35
unable or unwilling to participate in post-discharge follow-up either in-person or virtually
unable to speak or understand English and/or Spanish
Trial design
Treatments tested in this trial
- Transitional Liver Clinic (TLC)
Treatment groups
1,000 Participants
are divided into 2 treatment groupsLocations
4University of Chicago60637, ChicagoIllinois, United States
Indiana University Division of Gastroenterolgy and Hepatology46202, IndianapolisIndiana, United States
University of Michigan48109, Ann ArborMichigan, United States
Albert Einstein Healthcare Network19141, PhiladelphiaPennsylvania, United States
Sponsors and collaborators
Indiana University
Lead sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator
Source ClinicalTrials.gov